Daratumumab Decreases Treg-Mediated Immunosuppression and Potentiates CD8+T-Cell-Induced Killing of Chronic Lymphocytic Leukemia (CLL) Cells Ex Vivo

被引:0
|
作者
Manna, Alak
Akhtar, Sharoon
Yi, Paul
Parikh, Sameer A.
Ding, Wei
Leis, Jose F.
Alegria, Victoria R.
Sher, Taimur
Malavasi, Fabio
Ailawadhi, Sikander
Chanan-Khan, Asher A.
Paulus, Aneel
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1736
引用
收藏
页数:2
相关论文
共 50 条
  • [31] CD1d expression on chronic lymphocytic leukemia B cells affects disease progression and induces T cell skewing in CD8 positive and CD4CD8 double negative T cells
    Zaborsky, Nadja
    Gassner, Franz Josef
    Asslaber, Daniela
    Reinthaler, Petra
    Denk, Ursula
    Flenady, Sabine
    Hofbauer, Josefina Pinon
    Danner, Barbara
    Rebhandl, Stefan
    Harrer, Andrea
    Geisberger, Roland
    Greil, Richard
    Egle, Alexander
    ONCOTARGET, 2016, 7 (31) : 49459 - 49469
  • [32] Impact of retronectin-mediated T cell activation on CD19-specific chimeric antigen receptor T cells in chronic lymphocytic leukemia patients
    Stock, S.
    Hoffmann, J. -M
    Schubert, M. -L
    Wang, L.
    Wang, S.
    Gong, W.
    Neuber, B.
    Gern, U.
    Schmitt, A.
    Mueller-Tidow, C.
    Dreger, P.
    Schmitt, M.
    Sellner, L.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 86 - 86
  • [33] Interleukin 4 content in chronic lymphocytic leukaemia (CLL) B cells and blood CD8+ T cells from B-CLL patients:: impact on clonal B-cell apoptosis
    Kay, NE
    Han, L
    Bone, N
    Williams, G
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 112 (03) : 760 - 767
  • [34] Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib Show Expansion of T-Cell Clonotypes Composed of Antitumor Cytotoxic CD8+T-Cells
    Baptista, Maria Joao
    Baskar, Sivasubramanian
    Keyvanfar, Keyvan
    Gaglione, Erika M.
    Ahn, Inhye E.
    Wiestner, Adrian
    Sun, Clare
    BLOOD, 2019, 134
  • [35] Correlation of decreased T-helper-1 cells with stage in CD-5 positive B-cell chronic lymphocytic leukemia (CLL) patients.
    McCaul, K
    Fernandez, L
    BLOOD, 1997, 90 (10) : 4103 - 4103
  • [36] Soluble CD14 is a novel monocyte-derived survival factor for chronic lymphocytic leukemia cells, which is induced by CLL cells in vitro and present at abnormally high levels in vivo
    Seiffert, Martina
    Schulz, Angela
    Ohl, Sibylle
    Doehner, Hartmut
    Stilgenbauer, Stephan
    Lichter, Peter
    BLOOD, 2010, 116 (20) : 4223 - 4230
  • [37] Ex-Vivo Characterization of Polyclonal Memory CD8+T-Cell Responses to PRAME-Specific Peptides in Patients with Acute Leukemia and Chronic Myeloid Leukemia
    Rezvani, Katayoun
    Yong, Agnes S. M.
    Tawab, Abdul
    Jafarpour, Behnam
    Eniafe, Rhoda
    Mielke, Stephan
    Savani, Bipin N.
    Keyvanfar, Keyvan
    Li Yixin
    Kurlander, Roger
    Barrett, A. John
    BLOOD, 2008, 112 (11) : 1001 - 1001
  • [38] Pharmacologic Inhibition of SUMO-Activating Enzyme (SAE) with TAK-981 Augments Interferon Signaling and Regulates T Cell Differentiation in Ex Vivo studies of Chronic Lymphocytic Leukemia (CLL)
    Lam, Vi
    Best, Scott R.
    Bruss, Nur
    Liu, Tingting
    Rowland, Taylor Hashiguchi
    Huszar, Dennis
    Danilov, Alexey
    BLOOD, 2019, 134
  • [39] Targeting CD38 is lethal to Breg-like chronic lymphocytic leukemia cells and Tregs, but restores CD8+ T-cell responses
    Manna, Alak
    Kellett, Timothy
    Aulakh, Sonikpreet
    Lewis-Tuffin, Laura J.
    Dutta, Navnita
    Knutson, Keith
    Chini, Eduardo
    Pinilla-Ibarz, Javier
    Lamanna, Nicole
    Manochakian, Rami
    Malavasi, Fabio
    Sher, Taimur
    Chanan-Khan, Asher A.
    Ailawadhi, Sikander
    Paulus, Aneel
    BLOOD ADVANCES, 2020, 4 (10) : 2143 - 2157
  • [40] Differential sensitivity of CD4+ and CD8+ T lymphocytes to the killing efficacy of Fas (Apo-1/CD95) ligand+ tumor cells in B chronic lymphocytic leukemia
    Tinhofer, I
    Marschitz, I
    Kos, M
    Henn, T
    Egle, A
    Villunger, A
    Greil, R
    BLOOD, 1998, 91 (11) : 4273 - 4281